Pfizer Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
PFIZER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pfizer Limited has informed the stock exchanges that its trading window will remain closed from the close of business on September 30, 2025, until 48 hours after the unaudited financial results for the quarter and half year ending September 30, 2025 are made public. This is a routine compliance measure under SEBI's Insider Trading Regulations to prevent insiders from trading while they may have access to unpublished price-sensitive financial information. The window closure signals that the company's Q2 and H1 FY26 results are due for release soon, though no specific date has been announced yet.
This is a standard regulatory filing and does not impact the stock price. Investors should note that the upcoming quarterly results announcement is likely in the next few weeks, which could be a trigger for stock movement depending on the actual numbers reported.